JAHA:心血管疾病患者体力活动与下呼吸道感染结局之间的相关性

2022-02-10 MedSci原创 MedSci原创

在心血管疾病患者中,与完全久坐相比,即使进行低水平的体力活动也能降低因下呼吸道感染导致的死亡和住院风险,并且研究人员观察到随着体力活动的增加,风险会逐渐降低。

证据表明,缺乏体力活动会增加各种疾病和全因死亡率的风险。根据这些数据,最近的威廉亚洲博彩公司 建议进行体力活动以获得更好的健康结局。然而,体力活动对感染免疫功能的影响尚未得到充分探究。下呼吸道感染是发病率和死亡率的主要原因,约占2017年全球所有死亡人数的5%,其结果在老年人和免疫功能低下的人群中尤为严重。

近日,心血管疾病领域权威杂志JAHA上发表了一篇研究文章,研究人员的目标是探究心血管疾病患者体力活动与下呼吸道感染结局之间的剂量反应关系。

研究人员使用韩国国民健康保险数据,确定了在2009年1月1日至2012年12月31日期间参加健康筛查的18至99岁(平均年龄为62.6±11.3岁;女性为49.6%)的心血管疾病患者(n=1048502),并随访至2018年的死亡和直至2019年的住院治疗情况。研究人员使用自我报告的问卷评估体力活动量并将其分为5组:0(完全久坐)、<500、500至999、1000至1499和≥1500代谢当量的任务分钟/周。

在控制各种混杂因素后,对于体力活动量为0(完全久坐)、<500、500至999、1000至1499和≥1500代谢当量的受试者发生下呼吸道感染的调整后风险比(95%CI)分别为1.00(参考)、0.74(0.70-0.78)、0.66(0.62-0.70)、0.52(0.47-0.57)和0.54(0.49-0.60),下呼吸道感染住院的分险比分别为1.00(参考)、0.84(0.83-0.85)、0.77(0.76-0.79)、0.72(0.70-0.73)和0.71(0.69-0.73)。假设0到2000代谢当量任务min/wk之间存在线性关联,每增加500代谢当量的的体力活动与下呼吸道感染死亡率和住院率分别降低22%和13%相关。老年人群中的这一负性关联强于年轻人群(交互作用P<0.01)。

由此可见,在心血管疾病患者中,与完全久坐相比,即使进行低水平的体力活动也能降低因下呼吸道感染导致的死亡和住院风险,并且研究人员观察到随着体力活动的增加,风险会逐渐降低。

原始出处:

Mi‐Hyang Jung.etal.Association of Physical Activity and Lower Respiratory Tract Infection Outcomes in Patients With Cardiovascular Disease.JAHA.2022.https://www.ahajournals.org/doi/10.1161/JAHA.121.023775

版权声明:
本网站所有内容来源注明为“williamhill asia 医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于williamhill asia 医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“williamhill asia 医学”。其它来源的文章系转载文章,或“williamhill asia 号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与williamhill asia 联系,williamhill asia 将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1799207, encodeId=7d0b1e99207eb, content=<a href='/topic/show?id=38e0e0670ff' target=_blank style='color:#2F92EE;'>#疾病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70670, encryptionId=38e0e0670ff, topicName=疾病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c859411, createdName=hmwwww, createdTime=Sat Sep 24 07:19:28 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1838039, encodeId=97ba183803925, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Mon Aug 29 21:19:28 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268751, encodeId=581a1268e5109, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Feb 11 13:19:28 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282572, encodeId=4e2512825e2d5, content=<a href='/topic/show?id=700239e0772' target=_blank style='color:#2F92EE;'>#呼吸道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39707, encryptionId=700239e0772, topicName=呼吸道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Fri Feb 11 13:19:28 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486543, encodeId=3c0e1486543d1, content=<a href='/topic/show?id=43e320132fa' target=_blank style='color:#2F92EE;'>#下呼吸道感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20132, encryptionId=43e320132fa, topicName=下呼吸道感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4608143316, createdName=循证小兵, createdTime=Fri Feb 11 13:19:28 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499019, encodeId=99bb1499019bc, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Fri Feb 11 13:19:28 CST 2022, time=2022-02-11, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1799207, encodeId=7d0b1e99207eb, content=<a href='/topic/show?id=38e0e0670ff' target=_blank style='color:#2F92EE;'>#疾病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70670, encryptionId=38e0e0670ff, topicName=疾病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c859411, createdName=hmwwww, createdTime=Sat Sep 24 07:19:28 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1838039, encodeId=97ba183803925, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Mon Aug 29 21:19:28 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268751, encodeId=581a1268e5109, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Feb 11 13:19:28 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282572, encodeId=4e2512825e2d5, content=<a href='/topic/show?id=700239e0772' target=_blank style='color:#2F92EE;'>#呼吸道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39707, encryptionId=700239e0772, topicName=呼吸道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Fri Feb 11 13:19:28 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486543, encodeId=3c0e1486543d1, content=<a href='/topic/show?id=43e320132fa' target=_blank style='color:#2F92EE;'>#下呼吸道感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20132, encryptionId=43e320132fa, topicName=下呼吸道感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4608143316, createdName=循证小兵, createdTime=Fri Feb 11 13:19:28 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499019, encodeId=99bb1499019bc, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Fri Feb 11 13:19:28 CST 2022, time=2022-02-11, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1799207, encodeId=7d0b1e99207eb, content=<a href='/topic/show?id=38e0e0670ff' target=_blank style='color:#2F92EE;'>#疾病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70670, encryptionId=38e0e0670ff, topicName=疾病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c859411, createdName=hmwwww, createdTime=Sat Sep 24 07:19:28 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1838039, encodeId=97ba183803925, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Mon Aug 29 21:19:28 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268751, encodeId=581a1268e5109, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Feb 11 13:19:28 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282572, encodeId=4e2512825e2d5, content=<a href='/topic/show?id=700239e0772' target=_blank style='color:#2F92EE;'>#呼吸道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39707, encryptionId=700239e0772, topicName=呼吸道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Fri Feb 11 13:19:28 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486543, encodeId=3c0e1486543d1, content=<a href='/topic/show?id=43e320132fa' target=_blank style='color:#2F92EE;'>#下呼吸道感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20132, encryptionId=43e320132fa, topicName=下呼吸道感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4608143316, createdName=循证小兵, createdTime=Fri Feb 11 13:19:28 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499019, encodeId=99bb1499019bc, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Fri Feb 11 13:19:28 CST 2022, time=2022-02-11, status=1, ipAttribution=)]
    2022-02-11 zhaohui6731
  4. [GetPortalCommentsPageByObjectIdResponse(id=1799207, encodeId=7d0b1e99207eb, content=<a href='/topic/show?id=38e0e0670ff' target=_blank style='color:#2F92EE;'>#疾病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70670, encryptionId=38e0e0670ff, topicName=疾病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c859411, createdName=hmwwww, createdTime=Sat Sep 24 07:19:28 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1838039, encodeId=97ba183803925, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Mon Aug 29 21:19:28 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268751, encodeId=581a1268e5109, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Feb 11 13:19:28 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282572, encodeId=4e2512825e2d5, content=<a href='/topic/show?id=700239e0772' target=_blank style='color:#2F92EE;'>#呼吸道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39707, encryptionId=700239e0772, topicName=呼吸道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Fri Feb 11 13:19:28 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486543, encodeId=3c0e1486543d1, content=<a href='/topic/show?id=43e320132fa' target=_blank style='color:#2F92EE;'>#下呼吸道感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20132, encryptionId=43e320132fa, topicName=下呼吸道感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4608143316, createdName=循证小兵, createdTime=Fri Feb 11 13:19:28 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499019, encodeId=99bb1499019bc, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Fri Feb 11 13:19:28 CST 2022, time=2022-02-11, status=1, ipAttribution=)]
    2022-02-11 zhmscau
  5. [GetPortalCommentsPageByObjectIdResponse(id=1799207, encodeId=7d0b1e99207eb, content=<a href='/topic/show?id=38e0e0670ff' target=_blank style='color:#2F92EE;'>#疾病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70670, encryptionId=38e0e0670ff, topicName=疾病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c859411, createdName=hmwwww, createdTime=Sat Sep 24 07:19:28 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1838039, encodeId=97ba183803925, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Mon Aug 29 21:19:28 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268751, encodeId=581a1268e5109, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Feb 11 13:19:28 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282572, encodeId=4e2512825e2d5, content=<a href='/topic/show?id=700239e0772' target=_blank style='color:#2F92EE;'>#呼吸道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39707, encryptionId=700239e0772, topicName=呼吸道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Fri Feb 11 13:19:28 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486543, encodeId=3c0e1486543d1, content=<a href='/topic/show?id=43e320132fa' target=_blank style='color:#2F92EE;'>#下呼吸道感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20132, encryptionId=43e320132fa, topicName=下呼吸道感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4608143316, createdName=循证小兵, createdTime=Fri Feb 11 13:19:28 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499019, encodeId=99bb1499019bc, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Fri Feb 11 13:19:28 CST 2022, time=2022-02-11, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1799207, encodeId=7d0b1e99207eb, content=<a href='/topic/show?id=38e0e0670ff' target=_blank style='color:#2F92EE;'>#疾病患者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=67, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70670, encryptionId=38e0e0670ff, topicName=疾病患者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c859411, createdName=hmwwww, createdTime=Sat Sep 24 07:19:28 CST 2022, time=2022-09-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1838039, encodeId=97ba183803925, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=56, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Mon Aug 29 21:19:28 CST 2022, time=2022-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1268751, encodeId=581a1268e5109, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Fri Feb 11 13:19:28 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1282572, encodeId=4e2512825e2d5, content=<a href='/topic/show?id=700239e0772' target=_blank style='color:#2F92EE;'>#呼吸道#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=39707, encryptionId=700239e0772, topicName=呼吸道)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2e94174, createdName=zhmscau, createdTime=Fri Feb 11 13:19:28 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1486543, encodeId=3c0e1486543d1, content=<a href='/topic/show?id=43e320132fa' target=_blank style='color:#2F92EE;'>#下呼吸道感染#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=20132, encryptionId=43e320132fa, topicName=下呼吸道感染)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4608143316, createdName=循证小兵, createdTime=Fri Feb 11 13:19:28 CST 2022, time=2022-02-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1499019, encodeId=99bb1499019bc, content=<a href='/topic/show?id=bb6f89e145a' target=_blank style='color:#2F92EE;'>#血管疾病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89714, encryptionId=bb6f89e145a, topicName=血管疾病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ccb99370406, createdName=andy2090, createdTime=Fri Feb 11 13:19:28 CST 2022, time=2022-02-11, status=1, ipAttribution=)]

相关威廉亚洲官网

亚洲人群研究:降低代谢综合征风险最多达近70%!谁能不赞一句母乳喂养好!

PLOS ONE:社区分娩妇女母乳喂养史与代谢综合征和心血管危险因素的关系:日本多机构合作队列研究

JAHA:容易焦虑、忧心的男性患心血管疾病、卒中和糖尿病的风险更大

一项追踪男性40年的最新研究显示,随着年龄的增长,经常担心的中年男性更容易发展出导致心脏病、卒中和2型糖尿病的风险因素。

柳叶刀中国超9万人前瞻研究:2017年ACC/AHA威廉亚洲博彩公司 定义高血压和7个理想心血管健康指标,对降低心血管疾病风险效果如何?

Lancet Reg Health West Pac. :2017年ACC/AHA威廉亚洲博彩公司 定义的高血压、理想心血管健康指标和心血管疾病风险:一项全国前瞻性队列研究

Circulation:做好简单生活7法则,“逆天改命”不是梦!可增加无冠心病年数高达20年!

Circulation:美国心脏协会的简单生活7法则:生活方式建议,多基因风险和冠心病的终生风险

JAMAD:银屑病和心血管疾病:一分的预防抵得上十分的治疗

银屑病和银屑病关节炎是炎症、免疫失调和加速心血管疾病的交叉点,推进包括完善和开发针对银屑病患者的可修改的心血管风险降低策略,皮肤病、风湿病和心脏病学领域之间的合作是关键。

JCEM:循环脂肪因子与心血管疾病之间的因果关系

该研究的结果揭示了抵抗素水平和房颤之间的因果关系,可能通过血压起作用,并表明趋化素与CAD、RBP4和HF之间存在潜在的因果关系。